UK Gets First Publicly Available Dedicated Cannabis Research Facility

Cannabinoid biotechnology company MediPen is launching its own dedicated 1,800-square-foot marijuana research facility this summer, which will also provide a platform for anyone looking to utilize its facilities for the purposes of driving innovation around the use of medicinal cannabis.

The company, which has had big success selling non-psychoactive CBD vaporizers that users claim to have a long list of medicinal benefits, is currently in the process of securing a license from the Home Office to import and work with controlled compounds found in cannabis so it can study the plant in greater detail.

RELATED: International Cannabis News

These include ?9-Tetrahydrocannabinol (THC), which will be studied in the laboratory with regard to cancer patients and with the aim of minimizing the negative impact of existing chemotherapy-based treatments such as nausea and vomiting through its antiemetic properties, along with attempting to suppress metastasis through inhibiting the proliferation of cancer cells.

Read more.

Receive Updates

No spam guarantee.

I agree to have my personal information transfered to MailChimp ( more information )

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Skip to toolbar